Wolverine Trading’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-1,287
Closed -$236K – 4661
2020
Q1
$169K Buy
+1,287
New +$130K ﹤0.01% 3776
2019
Q4
– Sell
-811
Closed -$82K – 4733
2019
Q3
$82K Buy
+811
New +$94.4K ﹤0.01% 3916
2019
Q1
– Sell
-506
Closed -$78.8K – 4639
2018
Q4
$79K Sell
506
-353
-41% -$70.1K ﹤0.01% 4055
2018
Q3
$222K Sell
859
-378
-31% -$94.8K ﹤0.01% 4124
2018
Q2
$174K Hold
1,237
– – ﹤0.01% 4472
2018
Q1
$174K Sell
1,237
-471
-28% -$71.2K ﹤0.01% 4472
2017
Q4
$222K Buy
1,708
+721
+73% +$91.7K ﹤0.01% 4010
2017
Q3
$122K Buy
+987
New +$101K ﹤0.01% 4007
2017
Q2
– Sell
-1,033
Closed -$90.6K – 4356
2017
Q1
$113K Sell
1,033
-634
-38% -$70.9K ﹤0.01% 3782
2016
Q4
$182K Buy
1,667
+465
+39% +$50.9K ﹤0.01% 3814
2016
Q3
$150K Buy
1,202
+545
+83% +$56.6K ﹤0.01% 3992
2016
Q2
$59K Buy
+657
New +$57.2K ﹤0.01% 3793

Other funds holding CTSO

Wolverine Trading's CTSO Position: Q2 2020 in Review

Wolverine Trading sold out of Cytosorbents Corp (CTSO) in Q2 2020, closing a stake of 1,287 shares — an estimated $236K sold.

Wolverine Trading first reported a position in CTSO in Q2 2016 and held it in 12 quarters. The position peaked at $222K in Q3 2018. 90 funds tracked by Wall St. Rank hold CTSO as of Q2 2020.

  • Wolverine Trading reported no remaining Cytosorbents Corp position as of Q2 2020 after selling out during the quarter.
  • Wolverine Trading sold 1,287 Cytosorbents Corp shares in Q2 2020, an estimated $236K.
  • Wolverine Trading first reported a position in Cytosorbents Corp in Q2 2016 and held it in 12 quarters.
  • Wolverine Trading's Cytosorbents Corp position peaked at $222K in Q3 2018.
  • 90 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.